Carlos
Solano Vercet
Publicaciones en las que colabora con Carlos Solano Vercet (20)
2023
-
Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study
BMJ open, Vol. 13, Núm. 7, pp. e071371
2021
-
Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers
Transplantation and Cellular Therapy, Vol. 27, Núm. 6, pp. 493.e1-493.e8
2019
-
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster after Autologous Stem Cell Transplantation: A Randomized Clinical Trial
JAMA - Journal of the American Medical Association, Vol. 322, Núm. 2, pp. 123-133
2015
-
Outcome of graft failure after allogeneic stem cell transplant: Study of 89 patients
Leukemia and Lymphoma, Vol. 56, Núm. 3, pp. 656-662
2013
-
Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach
Biology of Blood and Marrow Transplantation, Vol. 19, Núm. 1, pp. 69-74
2011
-
Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab
Expert Review of Hematology, Vol. 4, Núm. 1, pp. 9-16
2010
2009
-
Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: A phase II trial
Leukemia and Lymphoma, Vol. 50, Núm. 2, pp. 216-222
2007
-
Tho adjusted International Prognostic Index and β-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma
Haematologica, Vol. 92, Núm. 8, pp. 1067-1074
2004
-
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: The GEL/TAMO experience
Annals of Oncology, Vol. 15, Núm. 10, pp. 1504-1509
2002
-
Myeloablative treatments for multiple myeloma: Update of a comparative study of different regimens used in patients from the Spanish Registry for transplantation in multiple myeloma
Leukemia and Lymphoma, Vol. 43, Núm. 1, pp. 67-74
2001
-
Allogeneic transplantation of CD34+ -selected cells from peripheral blood in patients with myeloid malignancies in early phase: A case control comparison with unmodified peripheral blood tranplantation
Bone Marrow Transplantation, Vol. 28, Núm. 4, pp. 349-354
-
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies
British Journal of Haematology, Vol. 114, Núm. 3, pp. 544-550
2000
-
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?
Hematology Journal, Vol. 1, Núm. 1, pp. 28-36
1999
-
Administration of recombinant human granulocyte colony-stimulating factor to normal donors: Results of the Spanish National Donor Registry
Bone Marrow Transplantation, Vol. 24, Núm. 7, pp. 723-728
1998
-
Autologous peripheral blood stem cell transplantation for multiple myeloma: A report of 259 cases from the Spanish Registry
Bone Marrow Transplantation, Vol. 21, Núm. 2, pp. 133-140
1997
-
Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia
Leukemia and Lymphoma, Vol. 25, Núm. 3-4, pp. 365-372
-
Trasplante alogénico de progenitores hemopoyéticos de sangre periférica no manipulados: Experiencia española de 79 casos
Sangre, Vol. 42, Núm. SUPPL. 1, pp. 42-43
-
Tratamiento de mantenimiento con interferón alfa en mieloma múltiple tras autotrasplante de progenitores hematopoyéticos de sangre periférica
Sangre, Vol. 42, Núm. SUPPL. 1, pp. 34-41
-
Tratamiento de mantenimiento con interferón alfa en mieloma múltiple tras autotrasplante de progenitores hematopoyéticos de sangre periférica. Registro Español de Trasplante en Mieloma.
Sangre, Vol. 42 Suppl 1, pp. 38-41